Skip to menu Skip to content Skip to footer

2022

Journal Article

Evaluation of a multidisciplinary integrated treatment approach versus standard model of care for Functional Gastrointestinal Disorders (FGIDS): a matched cohort study

Bray, Nicola A., Koloski, Natasha A., Jones, Michael P., Do, Anh, Pang, Siong, Coombes, Jeff S., McAllister, Sarah, Campos, Jane, Arthur, Leela, Stanley, Paul, DeMaria, Katherine, Chao, Che-yung, Catague, Rachel, Whaley, Amanda, Talley, Nicholas J. and Holtmann, Gerald J. (2022). Evaluation of a multidisciplinary integrated treatment approach versus standard model of care for Functional Gastrointestinal Disorders (FGIDS): a matched cohort study. Digestive Diseases and Sciences, 67 (12), 1-9. doi: 10.1007/s10620-022-07464-1

Evaluation of a multidisciplinary integrated treatment approach versus standard model of care for Functional Gastrointestinal Disorders (FGIDS): a matched cohort study

2022

Journal Article

Overlap of heartburn, functional dyspepsia, and irritable bowel syndrome in a population sample: prevalence, temporal stability, and associated comorbidities

Jones, Michael P., Shah, Ayesha, Walker, Marjorie M., Koloski, Natasha A., Holtmann, Gerald and Talley, Nicholas J. (2022). Overlap of heartburn, functional dyspepsia, and irritable bowel syndrome in a population sample: prevalence, temporal stability, and associated comorbidities. Neurogastroenterology and Motility, 34 (9) e14349, e14349. doi: 10.1111/nmo.14349

Overlap of heartburn, functional dyspepsia, and irritable bowel syndrome in a population sample: prevalence, temporal stability, and associated comorbidities

2022

Journal Article

Defects in NLRP6, autophagy and goblet cell homeostasis are associated with reduced duodenal CRH receptor 2 expression in patients with functional dyspepsia

Bruce, Jessica K., Burns, Grace L., Sinn Soh, Wai, Nair, Prema M., Sherwin, Simonne, Fan, KeNing, Dowling, Laura R., Goggins, Bridie J., Koloski, Natasha, Potter, Michael, Bollipo, Steven, Foster, Robert, Gan, Lay T., Veysey, Martin, Philpott, Dana J., Girardin, Stephen E., Holtmann, Gerald, Kaiko, Gerard E., Walker, Marjorie M., Talley, Nicholas J. and Keely, Simon (2022). Defects in NLRP6, autophagy and goblet cell homeostasis are associated with reduced duodenal CRH receptor 2 expression in patients with functional dyspepsia. Brain, Behavior, and Immunity, 101, 335-345. doi: 10.1016/j.bbi.2022.01.019

Defects in NLRP6, autophagy and goblet cell homeostasis are associated with reduced duodenal CRH receptor 2 expression in patients with functional dyspepsia

2022

Journal Article

Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial

Peyrin-Biroulet, Laurent, Hart, Ailsa, Bossuyt, Peter, Long, Millie, Allez, Matthieu, Juillerat, Pascal, Armuzzi, Alessandro, Loftus, Edward V, Ostad-Saffari, Elham, Scalori, Astrid, Oh, Young S, Tole, Swati, Chai, Akiko, Pulley, Jennifer, Lacey, Stuart, Sandborn, William J, Aguilar, Humberto, Ahmad, Tariq, Akriviadis, Evangelos, Aldeguer Mante, Xavier, Altorjay, Istvan, Ananthakrishnan, Ashwin, Andersen, Vibeke, Andreu Garcia, Montserrat, Aumais, Guy, Avni-Biron, Irit, Axler, Jeffrey, Ayub, Kamran, Baert, Filip ... Zeuzem, Stefan (2022). Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial. The Lancet Gastroenterology and Hepatology, 7 (2), 128-140. doi: 10.1016/S2468-1253(21)00298-3

Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial

2022

Journal Article

Updated S3 guideline on intestinal motility disorders: Definition, pathophysiology, diagnosis and treatment. Joint guideline of the German Society for Gastroenterology, Digestive and Metabolic Diseases (DGVS) and the German Society for Neurogastroenterology and Motility (DGNM). June 2021 - AWMF Register No.: 021-018 Update S3-Leitlinie Intestinale Motilitätsstörungen: Definition, Pathophysiologie, Diagnostik und Therapie. Gemeinsame Leitlinie der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Neurogastroenterologie und Motilität (DGNM)

Keller, Jutta, Wedel, Thilo, Seidl, Holger, Kreis, Martin E., Van Der Voort, Ivo, Gebhard, Maximilian, Langhorst, Jost, Lynen Jansen, Petra, Schwandner, Oliver, Storr, Martin, Van Leeuwen, Pia, Andresen, Viola, Preiβ, Jan C., Layer, Peter, Allescher, H., Andus, T., Bischoff, S. C., Buderus, S., Claβen, M., Ehlert, U., Elsenbruch, S., Engel, M., Enninger, A., Fischbach, W., Freitag, M., Frieling, T., Gillessen, A., Goebel-Stengel, M., Gschossmann, J. ... Von Schönfeld, J. (2022). Updated S3 guideline on intestinal motility disorders: Definition, pathophysiology, diagnosis and treatment. Joint guideline of the German Society for Gastroenterology, Digestive and Metabolic Diseases (DGVS) and the German Society for Neurogastroenterology and Motility (DGNM). June 2021 - AWMF Register No.: 021-018 Update S3-Leitlinie Intestinale Motilitätsstörungen: Definition, Pathophysiologie, Diagnostik und Therapie. Gemeinsame Leitlinie der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Neurogastroenterologie und Motilität (DGNM). Zeitschrift fur Gastroenterologie, 60 (2), 192-218. doi: 10.1055/a-1646-1279

Updated S3 guideline on intestinal motility disorders: Definition, pathophysiology, diagnosis and treatment. Joint guideline of the German Society for Gastroenterology, Digestive and Metabolic Diseases (DGVS) and the German Society for Neurogastroenterology and Motility (DGNM). June 2021 - AWMF Register No.: 021-018 Update S3-Leitlinie Intestinale Motilitätsstörungen: Definition, Pathophysiologie, Diagnostik und Therapie. Gemeinsame Leitlinie der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Neurogastroenterologie und Motilität (DGNM)

2022

Journal Article

Duodenal eosinophils and mast cells in functional dyspepsia: a systematic review and meta-analysis of case-control studies

Shah, Ayesha, Fairlie, Thomas, Brown, Georgia, Jones, Michael P., Eslick, Guy D., Duncanson, Kerith, Thapar, Nikhil, Keely, Simon, Koloski, Natasha, Shahi, Mohit, Walker, Marjorie M., Talley, Nicholas J. and Holtmann, Gerald (2022). Duodenal eosinophils and mast cells in functional dyspepsia: a systematic review and meta-analysis of case-control studies. Clinical Gastroenterology and Hepatology, 20 (10), 2229-2242.e29. doi: 10.1016/j.cgh.2022.01.014

Duodenal eosinophils and mast cells in functional dyspepsia: a systematic review and meta-analysis of case-control studies

2022

Journal Article

Small intestinal bacterial overgrowth in inflammatory bowel disease

Shah, Ayesha and Holtmann, Gerald (2022). Small intestinal bacterial overgrowth in inflammatory bowel disease. Indian Journal of Gastroenterology, 41 (1), 23-29. doi: 10.1007/s12664-021-01235-y

Small intestinal bacterial overgrowth in inflammatory bowel disease

2022

Journal Article

Etrolizumab versus adalimumab or placebo as induction therapy for moderately to severely active ulcerative colitis (HIBISCUS): two phase 3 randomised, controlled trials

Rubin, David T, Dotan, Iris, DuVall, Aaron, Bouhnik, Yoram, Radford-Smith, Graham, Higgins, Peter D R, Mishkin, Daniel S, Arrisi, Pablo, Scalori, Astrid, Oh, Young S, Tole, Swati, Chai, Akiko, Chamberlain-James, Kirsten, Lacey, Stuart, McBride, Jacqueline, Panés, Julian, Abdulkhakov, Rustem, Abu Bakar, Norasiah, Aguilar, Humberto, Aizenberg, Diego, Akpinar, Hale, Akriviadis, Evangelos, Alexeeva, Olga, Alikhanov, Bagdadi, Alvarisqueta, Andres, Ananthakrishnan, Ashwin, Andrews, Jane, Arlukowicz, Tomasz, Atkinson, Nathan ... on behalf of the HIBISCUS Study Group (2022). Etrolizumab versus adalimumab or placebo as induction therapy for moderately to severely active ulcerative colitis (HIBISCUS): two phase 3 randomised, controlled trials. The Lancet Gastroenterology and Hepatology, 7 (1), 17-27. doi: 10.1016/S2468-1253(21)00338-1

Etrolizumab versus adalimumab or placebo as induction therapy for moderately to severely active ulcerative colitis (HIBISCUS): two phase 3 randomised, controlled trials

2021

Journal Article

The role of mood state and emotion regulation in the discrepancy between gastrointestinal symptom burden recorded prospectively and via recall questionnaire

Jones, Michael P., Yun, Grace, Wass, Fiona, Rixon, Hayley, Shah, Ayesha, Walker, Marjorie M., Koloski, Natasha A., Holtmann, Gerald, Talley, Nicholas J. and Beath, Alissa P. (2021). The role of mood state and emotion regulation in the discrepancy between gastrointestinal symptom burden recorded prospectively and via recall questionnaire. Neurogastroenterology and Motility, 34 (7) e14304, 1-8. doi: 10.1111/nmo.14304

The role of mood state and emotion regulation in the discrepancy between gastrointestinal symptom burden recorded prospectively and via recall questionnaire

2021

Journal Article

Clusters of community-dwelling individuals empirically derived from stool diaries correspond with clinically meaningful outcomes

Jones, Michael P., Walter, Susanna, Talley, Nicholas J., Walker, Marjorie M., Holtmann, Gerald J., Shah, Ayesha, D'Amato, Mauro, Agréus, Lars and Andreasson, Anna (2021). Clusters of community-dwelling individuals empirically derived from stool diaries correspond with clinically meaningful outcomes. European Journal of Gastroenterology and Hepatology, 33 (S1), e740-e745. doi: 10.1097/MEG.0000000000002236

Clusters of community-dwelling individuals empirically derived from stool diaries correspond with clinically meaningful outcomes

2021

Journal Article

S3 guideline update on irritable bowel syndrome: Definition, pathophysiology, diagnosis and treatment. Joint guidelines of the German Society for Gastroenterology, Digestive and Metabolic Diseases (DGVS) and the German Society for Neurogastroenterology and Motility (DGNM). June 2021 - AWMF Register No.: 021/016 Update S3-leitlinie reizdarmsyndrom: Definition, pathophysiologie, diagnostik und therapie. Gemeinsame Leitlinie der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für neurogastroenterologie und Motilität (DGNM) Juni 2021 - AWMF-registriernummer: 021/016

Layer, Peter, Andresen, Viola, Allescher, H., Bischoff, S. C., Claßen, M., Elsenbruch, S., Freitag, M., Frieling, T., Gebhard, M., Goebel-Stengel, M., Häuser, W., Holtmann, G., Keller, J., Kreis, M. E., Kruis, W., Langhorst, J., Jansen, P. Lynen, Madisch, A., Mönnikes, H., Müller-Lissner, S., Niesler, B., Pehl, C., Pohl, D., Raithel, M., Röhrig-Herzog, G., Schemann, M., Schmiedel, S., Schwille-Kiuntke, J., Storr, M. ... Wedel, T. (2021). S3 guideline update on irritable bowel syndrome: Definition, pathophysiology, diagnosis and treatment. Joint guidelines of the German Society for Gastroenterology, Digestive and Metabolic Diseases (DGVS) and the German Society for Neurogastroenterology and Motility (DGNM). June 2021 - AWMF Register No.: 021/016 Update S3-leitlinie reizdarmsyndrom: Definition, pathophysiologie, diagnostik und therapie. Gemeinsame Leitlinie der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für neurogastroenterologie und Motilität (DGNM) Juni 2021 - AWMF-registriernummer: 021/016. Zeitschrift fur Gastroenterologie, 59 (12), 1323-1415. doi: 10.1055/a-1591-4794

S3 guideline update on irritable bowel syndrome: Definition, pathophysiology, diagnosis and treatment. Joint guidelines of the German Society for Gastroenterology, Digestive and Metabolic Diseases (DGVS) and the German Society for Neurogastroenterology and Motility (DGNM). June 2021 - AWMF Register No.: 021/016 Update S3-leitlinie reizdarmsyndrom: Definition, pathophysiologie, diagnostik und therapie. Gemeinsame Leitlinie der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für neurogastroenterologie und Motilität (DGNM) Juni 2021 - AWMF-registriernummer: 021/016

2021

Journal Article

Electroencephalographic evidence of unconscious and conscious attentional bias in people with functional gastrointestinal disorders: A pilot study

Ejova, Anastasia, Badcock, Nicholas A., McKerchar, Sarah, Beath, Alissa P., Swift, Claire, Talley, Nicholas J., Holtmann, Gerald, Walker, Marjorie M. and Jones, Michael P. (2021). Electroencephalographic evidence of unconscious and conscious attentional bias in people with functional gastrointestinal disorders: A pilot study. International Journal of Psychophysiology, 170, 30-42. doi: 10.1016/j.ijpsycho.2021.09.006

Electroencephalographic evidence of unconscious and conscious attentional bias in people with functional gastrointestinal disorders: A pilot study

2021

Journal Article

Autism-related dietary preferences mediate autism-gut microbiome associations

Yap, Chloe X., Henders, Anjali K., Alvares, Gail A., Wood, David L.A., Krause, Lutz, Tyson, Gene W., Restuadi, Restuadi, Wallace, Leanne, McLaren, Tiana, Hansell, Narelle K., Cleary, Dominique, Grove, Rachel, Hafekost, Claire, Harun, Alexis, Holdsworth, Helen, Jellett, Rachel, Khan, Feroza, Lawson, Lauren P., Leslie, Jodie, Frenk, Mira Levis, Masi, Anne, Mathew, Nisha E., Muniandy, Melanie, Nothard, Michaela, Miller, Jessica L., Nunn, Lorelle, Holtmann, Gerald, Strike, Lachlan T., de Zubicaray, Greig I. ... Gratten, Jacob (2021). Autism-related dietary preferences mediate autism-gut microbiome associations. Cell, 184 (24), 5916-5931.e17. doi: 10.1016/j.cell.2021.10.015

Autism-related dietary preferences mediate autism-gut microbiome associations

2021

Journal Article

Antibiotic use but not gastrointestinal infection frequently precedes first diagnosis of functional gastrointestinal disorders

Jones, Michael P., Shah, Ayesha, Walker, Marjorie M., Koloski, Natasha A., Holtmann, Gerald and Talley, Nicholas J. (2021). Antibiotic use but not gastrointestinal infection frequently precedes first diagnosis of functional gastrointestinal disorders. United European Gastroenterology Journal, 9 (9), 1074-1080. doi: 10.1002/ueg2.12164

Antibiotic use but not gastrointestinal infection frequently precedes first diagnosis of functional gastrointestinal disorders

2021

Journal Article

Physician perceptions on the use of antibiotics and probiotics in adults: an international survey in the Asia-Pacific area

Ghoshal, Uday C., Gwee, Kok-Ann, Holtmann, Gerald, Li, Yanmei, Park, Soo Jung, Simadibrata, Marcellus, Sugano, Kentaro, Cohen, Henry and Quigley, Eamonn M. M. (2021). Physician perceptions on the use of antibiotics and probiotics in adults: an international survey in the Asia-Pacific area. Frontiers in Cellular and Infection Microbiology, 11 722700, 722700. doi: 10.3389/fcimb.2021.722700

Physician perceptions on the use of antibiotics and probiotics in adults: an international survey in the Asia-Pacific area

2021

Journal Article

Draft genome sequence of streptococcus salivarius AGIRA0003, isolated from functional gastrointestinal disorder duodenal tissue

Hoedt, Emily C., Shanahan, Erin R., Keely, Simon, Shah, Ayesha, Burns, Grace L., Holtmann, Gerald J., Talley, Nicholas J. and Morrison, Mark (2021). Draft genome sequence of streptococcus salivarius AGIRA0003, isolated from functional gastrointestinal disorder duodenal tissue. Microbiology Resource Announcements, 10 (39) e00758, e0075821. doi: 10.1128/MRA.00758-21

Draft genome sequence of streptococcus salivarius AGIRA0003, isolated from functional gastrointestinal disorder duodenal tissue

2021

Journal Article

Sleep disturbances in the irritable bowel syndrome and functional dyspepsia are independent of psychological distress: a population-based study of 1322 Australians

Koloski, Natasha A., Jones, Michael, Walker, Marjorie M., Keely, Simon, Holtmann, Gerald and Talley, Nicholas J. (2021). Sleep disturbances in the irritable bowel syndrome and functional dyspepsia are independent of psychological distress: a population-based study of 1322 Australians. Alimentary Pharmacology and Therapeutics, 54 (5) apt.16500, 627-636. doi: 10.1111/apt.16500

Sleep disturbances in the irritable bowel syndrome and functional dyspepsia are independent of psychological distress: a population-based study of 1322 Australians

2021

Conference Publication

Differentiation and capture of the human duodenal mucosa-associated microbiota by a novel ex vivo combination of microbe culture and metagenomic sequencing

Schooth, L., Kang, S., Lim, Y., Shah, A., Fairlie, T., Jimenez-Loayza, J., Teh, J.-J., Holtmann, G. and Morrison, M. (2021). Differentiation and capture of the human duodenal mucosa-associated microbiota by a novel ex vivo combination of microbe culture and metagenomic sequencing. GESA AGW 2021, Online, 4-12 September 2021. Richmond, VIC Australia: Wiley-Blackwell.

Differentiation and capture of the human duodenal mucosa-associated microbiota by a novel ex vivo combination of microbe culture and metagenomic sequencing

2021

Journal Article

Letter to the Editor: Oral Vancomycin Versus No Therapy for Pediatric Primary Sclerosing Cholangitis

Johnson, Kevin M., Fischer, Ryan T., Holtmann, Gerald J., Shah, Ayesha, Alrabadi, Leina and Lewindon, Peter (2021). Letter to the Editor: Oral Vancomycin Versus No Therapy for Pediatric Primary Sclerosing Cholangitis. Hepatology, 74 (3), 1716-1717. doi: 10.1002/hep.31764

Letter to the Editor: Oral Vancomycin Versus No Therapy for Pediatric Primary Sclerosing Cholangitis

2021

Journal Article

Concomitant irritable bowel syndrome does not influence the response to antimicrobial therapy in patients with functional dyspepsia

Shah, Ayesha, Gurusamy, Saravana Ruban, Hansen, Teressa, Callaghan, Gavin, Talley, Nicholas J., Koloski, Natasha, Walker, Marjorie M., Jones, Michael P., Morrison, Mark and Holtmann, Gerald J. (2021). Concomitant irritable bowel syndrome does not influence the response to antimicrobial therapy in patients with functional dyspepsia. Digestive Diseases and Sciences, 67 (6), 2299-2309. doi: 10.1007/s10620-021-07149-1

Concomitant irritable bowel syndrome does not influence the response to antimicrobial therapy in patients with functional dyspepsia